When all else fails....
Article 120 Transitional provisions1.From 26 May 2020, any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void.
Article 122 Repeal
Without prejudice to Articles 120(3) and (4) of this Regulation, and without prejudice to the obligations of the Member States and manufacturers as regards vigilance and to the obligations of manufacturers as regards the making available of documentation, under Directives 90/385/EEC and 93/42/EEC, those Directives are repealed with effect from 26 May 2020, with the exception of:
- Articles 8 and 10, points (b) and (c) of Article 10b(1), Article 10b(2) and Article 10b(3) of Directive 90/385/EEC, and the obligations relating to vigilance and clinical investigations provided for in the corresponding Annexes, which are repealed with effect from the later of the dates referred to in point (d) of Article 123(3) of this Regulation;
- Article 10a and point (a) of Article 10b(1) of Directive 90/385/EEC, and the obligations relating to registration of devices and economic operators, and to certificate notifications, provided for in the corresponding Annexes, which are repealed with effect from 18 months after the later of the dates referred to in point (d) of Article 123(3) of this Regulation;
- Article 10, points (c) and (d) of Article 14a(1), Article 14a(2), Article 14a(3) and Article 15 of Directive 93/42/EEC, and the obligations relating to vigilance and clinical investigations provided for in the corresponding Annexes, which are repealed with effect from the later of the dates referred to in point (d) of Article 123(3) of this Regulation; and 5.5.2017 L 117/90 Official Journal of the European Union EN
- Article 14(1) and (2) and points (a) and (b) of Article 14a(1) of Directive 93/42/EEC, and the obligations relating to registration of devices and economic operators, and to certificate notifications, provided for in the corresponding Annexes, which are repealed with effect from 18 months after the later of the dates referred to in point (d) of Article 123(3) of this Regulation.
As regards the devices referred to in Article 120 (3) and (4) of this Regulation, the Directives referred to in the first paragraph shall continue to apply until 27 May 2025 to the extent necessary for the application of those paragraphs.
I am not sure this covers all applicable text, but I find things can sometimes get more confusing when people quote snippets in the interest of brevity.------------------------------
Julie Omohundro, ex-RAC (US, GS), still an MBA
Principal Consultant
Class Three, LLC
Mebane, North Carolina, USA
919-544-3366 (T)
434-964-1614 (C)
julie@class3devices.com------------------------------
Original Message:
Sent: 24-Jan-2020 19:20
From: Dan O'Leary
Subject: Input needed from MDR gurus!
Let me clarify the situation.
On the date of application of the MDR, the MDD does not become void. It will live on for many years.
In the MDR Article 120(1) it is the notification of the NB that becomes void. This means there will be no new MDD NBs nor new device certificates to the MDD.
Article 120(3)(second paragraph) says that the NB that issued the certificate is responsible for surveillance.
So, when the NB conducts surveillance what are the requirements? The answer is in Article 120(3). The manufacturer must comply with the MDD except for (as enumerated):
No significant design changes
No significant intended use changes
Post-market surveillance from the MDR, not the MDD
Market surveillance from the MDR, not the MDD
Vigilance from the MDR, not the MDD
Economic operator registration from the MDR, not the MDD
Device registration from the MDR, not the MDD
As a result, the device is not fully compliant with the MDD. Also, the device is not fully compliant with the MDR. It is compliant with a hybrid, the MDD as modified by MDR Article 120. The DoC must be correct, so it must state the hybrid state.
------------------------------
Dan O'Leary CQA, CQE
Swanzey NH
United States
Original Message:
Sent: 24-Jan-2020 09:49
From: Peter Reijntjes
Subject: Input needed from MDR gurus!
That is a way of looking at it, let me put it forward the other way around.
After the date of application of the MDR the MDD is also declared void (or other terminology) and for medical devices only the MDR is applicable. As an 'escape' the transitional provisions have been identified. A manufacturer uses the Declaration of Conformity to declare compliance with MDR art. 120 and makes reference to the applicable (MDD) CE-certificate. So far so good.
I know that you suggested the same thing on the DoC, but the other way around; I think is not possible to claim compliance to a Directive which is void. However I think one can claim compliance to the requirements of that void Directive via compliance with MDR article 120. I know this is not stated as such in art 120(3).
Another thing is:
Article 120(3) also states that 'Without prejudice to Chapter IV and paragraph 1 of this Article, the notified body that issued the certificate referred to in the first subparagraph shall continue to be responsible for the appropriate surveillance in respect of all of the applicable requirements relating to the devices it has certified.'
My question/uncertainty is how can a Notified Body still be notified for a Directive that has become void? I do not think that it is possible.
And how can a Notified Body, not yet or not at all been designated for the MDR in time, assess the implementation of all the applicable the requirements in MDR article 120(3) in an appropriate way when they have not been assessed and approved to do so?
This whole article 120 seems to be legally rather shaky and unclear to me. It puzzles me.
And this is not the only issue in the MDR which puzzles me...…. :-)
------------------------------
Peter Reijntjes
Principal Consultant Regulatory & Quality Affairs
Arnhem
Netherlands
Original Message:
Sent: 24-Jan-2020 08:42
From: Dan O'Leary
Subject: Input needed from MDR gurus!
You ask, "Regarding the state of the Notified Bodies they (should) mimic above mentioned states, although I have not yet seen a designation of a Notified Body under article 120!? What happens if a Notified Body is not designated for MDR in time? Are they allowed to monitor the manufacturers and their products after 26 May 2020? Does somebody have information on this?"
The NBs do not get separate recognition for MDR Article 120. They operate under the MDD, so an NB without an MDR designation can still handle devices under Article 120.
In my analysis a device, not a manufacturer nor an NB, can be in one of three states:
Under full MDD
Under MDD as modified by MDR Article 120
Under full MDR
For the first two cases the NB must be designated for the MDD. For the third case the NB must be designated for the MDR.
------------------------------
Dan O'Leary CQA, CQE
Swanzey NH
United States
Original Message:
Sent: 24-Jan-2020 04:23
From: Peter Reijntjes
Subject: Input needed from MDR gurus!
Hi Kevin, your statement 'Just being self declared class I was enough to be able to take advantage of the transition period' is not entirely correct.
Class I products (under MDD) of which the classification under the MDR remains the same cannot make use of the transitional provisions of article 120 because they do not have a CE certificate which is a pre-requisite for the use of article 120. Only when a class I product (under MDD) requires the involvement of a Notified Body under MDR (upclassification) they may be placed on the market until 26 May 2024 when the requirements of article 120 are met - As stated in Corrigendum 2.
Regarding the conformance of products Dan O'Leary puts it like this:
- It meets the requirements under the MDD/AIMD
- It is an EU-MDR Article 120 device
- It is an EU-MDR device
As of 27 May 2020 the first state cannot be claimed anymore; the second state is piggy-bagging on a valid MDD CE-certificate under the restrictions and obligations of MDR article 120(3) and the third state being in full compliance with MDR.
Its my opinion that after 26 May 2020 there are no MDD compliant devices anymore, only state 1 and state 2 MDR compliant products. The Declaration of Conformity should show which of both states is claimed, meaning that all DoCs have to be updated before 27 May 2020.
Regarding the state of the Notified Bodies they (should) mimic above mentioned states, although I have not yet seen a designation of a Notified Body under article 120!? What happens if a Notified Body is not designated for MDR in time? Are they allowed to monitor the manufacturers and their products after 26 May 2020? Does somebody have information on this?
------------------------------
Peter Reijntjes
Principal Consultant Regulatory & Quality Affairs
Arnhem
Netherlands
Original Message:
Sent: 23-Jan-2020 16:00
From: Julie Omohundro
Subject: Input needed from MDR gurus!
OK, one more clarification would be appreciated! Are there ANY devices...of ANY type or classification...that DO NOT have to conform to the MDR as of May 26? Various devices are being given more time to get a certificate, but at least some still have to otherwise conform to the MDR as of May 26, right? Are there any that do not? (Other than IVDs, of course!!!)
Can someone PLEASE clear this up?
Thanks...
------------------------------
Julie Omohundro, ex-RAC (US, GS), still an MBA
Principal Consultant
Class Three, LLC
Mebane, North Carolina, USA
919-544-3366 (T)
434-964-1614 (C)
julie@class3devices.com
Original Message:
Sent: 16-Jan-2020 19:08
From: Julie Omohundro
Subject: Input needed from MDR gurus!
I'm trying to work out a high-level look at the impact the MDR is likely to have on the number of medical devices on the EU market before and after May 26. Here's what I have so far. I would be happy to have any corrections, additions, suggestions, or other comments from some of the MDR gurus here might offer, as I am not one:
Expiration and Renewal Timeframes for MDD-Certified Class II-III Medical Devices
MDD Certified Class II-III Devices
|
Issued
|
Expiration
|
Renewable
|
Expiring
|
Group A (20%)
|
May 27 2012 to May 26 2013
|
May 26 2017 to May 25 2018
|
May 27 2017 to May 26 2018
|
May 26 2022 to May 25 2023
|
Group B (20%)
|
May 27 2013 to May 26 2014
|
May 26 2018 to May 25 2019
|
May 27 2018 to May 26 2019
|
May 26 2023 to May 25 2024
|
Group C (20%)
|
May 27 2014 to May 26 2015
|
May 26 2019 to May 25 2020
|
May 27 2019 to May 26 2020
|
May 26 2024 to May 25 2025
|
Group D (20%)
|
May 27 2015 to May 26 2016
|
May 26 2020 to May 25 2021
|
No
|
|
Group E (20%)
|
May 27 2016 to May 26 2017
|
May 26 2021 to May 25 2022
|
No
|
|
Groups A and B
These devices are in one of two situations:
- The NB that issued their MDD certificates will continue to provide NB services through the transition. In this case, these devices can remain on the EU market without an MDR-designated NB for another 2-4 years. They must still conform to the requirements of the MDR.
- The NB that issued their MDD certificates will not continue to provide NB services through the transition. Apparently the main determinant here is whether their medical device staff think that their employer will eventually be MDR-designated. If not, they are prone to a sudden desire to seek their future elsewhere, leaving no one left to provide the services.
According to the October 2019 Joint Assessments Report, 40 notified bodies have sought designation under the MDR. As of now, 9 have been designated. Whether any of the remaining 31 will fail to secure designation is unknown, but it seems probable that these 40 NBs were still renewing MDD certificates through May 25 2019 and that their staff feel no pressing need to seek employment elsewhere, so they currently are expecting to offer MDD services through the transition.
Therefore, as of now, most of the devices in Groups A and B will apparently be able to ride their MDD certificates through at least May 26 2022.
Group C
These devices give new meaning to being "at an awkward age." If their manufacturers were very forward looking, they renewed their MDD certifications early, which puts them in the same position as the devices in Groups A and B. But probably few of their manufacturers expected NB capacity to get this tight, so they probably decided they would forego renewal for these devices and pursue MDR designation instead. Oops. Some of these devices--those that had MDD certification from an NB that secured MDR designation in 2019--will get MDR certification by May 26, but the majority will probably still be waiting in queue.
Groups D and E
None of the devices in these groups can ride their MDD certificates past May 26, so their manufacturers should have started to prepare early. Those that were fortunate enough to hold MDD certificates from one of the NBs that were certified in 2019 should be well positioned to get their certificates by May 26, or shortly enough thereafter so as not to be a huge problem. The same is true for a small percentage holding MDD certificates from NBs certified in early 2020. The rest will probably get MDR certificates sometime in 2020…IF the NB that holds their MDD certificates gets MDR designated.
------------------------------
Julie Omohundro, ex-RAC (US, GS), still an MBA
Principal Consultant
Class Three, LLC
Mebane, North Carolina, USA
919-544-3366 (T)
434-964-1614 (C)
julie@class3devices.com
------------------------------